Carmofur, CAS [[61422-45-5]]

Produktübersicht

• Artikelname: Carmofur, CAS [[61422-45-5]]
• Artikelnummer: MCE-HY-B0182
• Hersteller Artikelnummer: HY-B0182
• Alternativnummer: MCE-HY-B0182-10MMX1ML,MCE-HY-B0182-25MG,MCE-HY-B0182-50MG,MCE-HY-B0182-100MG,MCE-HY-B0182-500MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: HCFU

Produktbeschreibung

Carmofur (HCFU) is a rat recombinant acid ceramidase inhibitor with an IC50 of 29 nM. Carmofur is also a protease inhibitor of SARS-CoV-2 main protease (Mpro), fatty acid amide hydrolase (FAAH) and N-acylethanolamine acid amidase (NAAA). Carmofur has anti-cancer, anti-inflammatory and anti-virus activities, and can be used for the study of COVID-19 and acute lung injury (ALI)[1][2][3].

Produkteigenschaften

• Molekulargewicht: 257.26
• Reinheit: 99.95
• CAS Nummer: [61422-45-5]
• Formel: C11H16FN3O3
• Target-Kategorie: Ceramidase,FAAH,Glutathione Peroxidase,Nucleoside Antimetabolite/Analog,SARS-CoV,Virus Protease

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound